Literature DB >> 11819345

Gastrin as an autocrine growth factor in colorectal carcinoma: implications for therapy.

Graham S Baldwin, Arthur Shulkes.   

Abstract

Entities:  

Year:  1998        PMID： 11819345      PMCID： PMC4723428          DOI： 10.3748/wjg.v4.i6.461

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  11 in total

Review 1.  Aspirin, NSAIDS, and colon cancer prevention: mechanisms?

Authors:  R A Gupta; R N DuBois
Journal:  Gastroenterology       Date:  1998-05       Impact factor: 22.682

2.  Processing and proliferative effects of human progastrin in transgenic mice.

Authors:  T C Wang; T J Koh; A Varro; R J Cahill; C A Dangler; J G Fox; G J Dockray
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines.

Authors:  N M Hoosein; P A Kiener; R C Curry; L C Rovati; D K McGilbra; M G Brattain
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

4.  Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line.

Authors:  F Hollande; A Imdahl; T Mantamadiotis; G D Ciccotosto; A Shulkes; G S Baldwin
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

5.  Expression, processing, and secretion of gastrin in patients with colorectal carcinoma.

Authors:  G D Ciccotosto; A McLeish; K J Hardy; A Shulkes
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

6.  Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein.

Authors:  G S Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

7.  Binding of nonsteroidal antiinflammatory drugs to the alpha-subunit of the trifunctional protein of long chain fatty acid oxidation.

Authors:  G S Baldwin; V J Murphy; Z Yang; T Hashimoto
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

8.  Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells.

Authors:  P Singh; A Owlia; A Varro; B Dai; S Rajaraman; T Wood
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

9.  Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer.

Authors:  S A Watson; D Michaeli; S Grimes; T M Morris; G Robinson; A Varro; T A Justin; J D Hardcastle
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

10.  Gastrin and colorectal cancer: a prospective study.

Authors:  C M Thorburn; G D Friedman; C J Dickinson; J H Vogelman; N Orentreich; J Parsonnet
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682
View more
  5 in total

1.  Flow cytometric detection of progastrin interaction with gastrointestinal cells.

Authors:  Alexander Dubeykovskiy; Thomas Nguyen; Zinaida Dubeykovskaya; Shi Lei; Timothy C Wang
Journal:  Regul Pept       Date:  2008-07-09

2.  Construction and evaluation of anti-gastrin immunogen based on P64K protein.

Authors:  Xiang-Hua Xiong; Hong-Liang Zhao; Chong Xue; Wei Zhang; Bing-Fen Yang; Xue-Qin Yao; Zhi-Min Liu
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 3.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

4.  Peptidergic innervation of human esophageal and cardiac carcinoma.

Authors:  Shuang-Hong Lü; Yan Zhou; Hai-Ping Que; Shao-Jun Liu
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

5.  Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.

Authors:  Li-Nien Chien; Yan-Jiun Huang; Yu-Hsuan Joni Shao; Chen-Jung Chang; Ming-Tsang Chuang; Hung-Yi Chiou; Yun Yen
Journal:  Int J Cancer       Date:  2015-11-20       Impact factor: 7.396
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.